Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands

Author(s):
Jochems, A.; Schouwenburg, M.G.; Leeneman, B.; Franken, M.G.; Eertwegh, A.J.M. van den; Haanen, J.B.A.G.; Gelderblom, H.; Uyl-de Groot, C.A.; Aarts, M.J.B.; Berkmortel, F.W.P.J. van den; Blokx, W.A.M.; Cardous-Ubbink, M.C.; Groenewegen, G.; Groot, J.W.B. de; Hospers, G.A.P.; Kapiteijn, E.; Koornstra, R.H.; Kruit, W.H.; Louwman, M.W.; Piersma, D.; Rijn, R.S. van; Tije, A.J. ten; Vreugdenhil, G.; Wouters, M.W.J.M.; Hoeven, J.J.M. van der (0000-0003-1117-1959)
Published
2017
Publication type
Article / Letter to editor
Quality assuranceMetastatic melanomaCheckpoint inhibitorsMAP kinase inhibitorsPopulation-basedRegistryIpilimumab
Date issued
2017-02-28
Language
English
Is part of
European Journal of Cancer (2017), Vol. 72, p. 156-165
hdl
1887/94724
doi
10.1016/j.ejca.2016.11.021